ArticleMolecular oncology2020

Overcoming acquired resistance of EGFR-mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol.

Hongjing Zang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.